U.S. Stem Cell, Inc. (USRM) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
1560 SAWGRASS CORPORATE PKWY SUNRISE, FL 33323 |
| State of Incorp. | FL |
| Fiscal Year End | December 31 |
| Industry (SIC) | 8731 - Commercial Physical and Biological Research (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 39 | 19 | 1,357 | 987 | 271 | ||||
| Cash and cash equivalent | 39 | 19 | 1,357 | 987 | 271 | ||||
| Receivables | 1 | 54 | 48 | 18 | 43 | 16 | |||
| Inventory, net of allowances, customer advances and progress billings | 0 | 5 | 8 | 93 | 70 | 42 | |||
| Inventory | 0 | 5 | 8 | 93 | 70 | 42 | |||
| Other undisclosed current assets | 10 | 10 | 10 | 38 | 3 | ||||
| Total current assets: | 51 | 88 | 66 | 1,507 | 1,103 | 329 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 243 | 450 | 21 | ||||||
| Deposits noncurrent assets | 10 | 10 | 10 | ||||||
| Other undisclosed noncurrent assets | 24 | 58 | 35 | 68 | |||||
| Total noncurrent assets: | 24 | 311 | 495 | 99 | |||||
| TOTAL ASSETS: | 51 | 88 | 90 | 1,817 | 1,598 | 428 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 3,996 | 2,822 | 2,334 | 2,428 | 2,396 | 2,195 | |||
| Settlement liabilities | ✕ | 27 | 29 | 30 | 89 | 89 | |||
| Interest and dividends payable | ✕ | 645 | |||||||
| Accounts payable | 1,373 | 1,282 | 1,188 | 1,183 | 1,378 | 1,290 | |||
| Accrued liabilities | 1,951 | 1,511 | 1,116 | 1,156 | 929 | 905 | |||
| Deferred revenue | 3 | 3 | 24 | ✕ | ✕ | ✕ | |||
| Debt | 2,558 | 1,407 | 1,299 | 687 | 1,548 | 4 | |||
| Derivative instruments and hedges, liabilities | 297 | ||||||||
| Other liabilities | |||||||||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | ✕ | 211 | 127 | ||
| Due to related parties | 951 | 861 | 512 | 235 | 105 | 105 | |||
| Other undisclosed current liabilities | 4,530 | 5,754 | 4,583 | 2,567 | 2,203 | 3,436 | |||
| Total current liabilities: | 12,039 | 10,848 | 8,751 | 5,917 | 6,463 | 6,164 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 722 | 760 | 756 | 1,338 | 1,493 | 1,229 | |||
| Long-term debt, excluding current maturities | 722 | 760 | 756 | 1,299 | 1,229 | 1,229 | |||
| Capital lease obligations | ✕ | ✕ | ✕ | ✕ | 40 | 265 | |||
| Liabilities, other than long-term debt | 57 | 60 | 63 | 129 | 197 | 72 | |||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | ✕ | 197 | 72 | ||
| Deferred revenue | 57 | 60 | 63 | ✕ | ✕ | ✕ | |||
| Deferred gain on sale of property | 129 | ✕ | ✕ | ||||||
| Other undisclosed noncurrent liabilities | 1,316 | 544 | 983 | ||||||
| Total noncurrent liabilities: | 779 | 820 | 819 | 2,783 | 2,235 | 2,283 | |||
| Total liabilities: | 12,817 | 11,667 | 9,569 | 8,699 | 8,698 | 8,446 | |||
| Equity | |||||||||
| Equity, attributable to parent | (12,766) | (11,579) | (9,479) | (6,882) | (7,100) | (8,019) | |||
| Preferred stock | 20 | ||||||||
| Common stock | 504 | 436 | 418 | 378 | 342 | 127 | |||
| Additional paid in capital | 126,532 | 124,500 | 123,727 | 122,528 | 120,186 | 115,981 | |||
| Accumulated deficit | (139,802) | (136,515) | (133,624) | (129,789) | (127,628) | (124,147) | |||
| Total equity: | (12,766) | (11,579) | (9,479) | (6,882) | (7,100) | (8,019) | |||
| TOTAL LIABILITIES AND EQUITY: | 51 | 88 | 90 | 1,817 | 1,598 | 428 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 201 | 277 | 3,072 | 6,701 | 5,521 | 3,083 | ||
| Revenue, net | ✕ | ✕ | ✕ | ✕ | ✕ | 5,521 | 3,083 | |
| Cost of revenue (Cost of Product and Service Sold) | (52) | (64) | (1,335) | (2,111) | (1,885) | (972) | ||
| Gross profit: | 149 | 213 | 1,737 | 4,590 | 3,635 | 2,111 | ||
| Operating expenses | (2,285) | (2,613) | (5,154) | (5,688) | (4,440) | (3,271) | ||
| Operating loss: | (2,136) | (2,400) | (3,417) | (1,098) | (805) | (1,160) | ||
| Nonoperating expense | (1,152) | (490) | (418) | (1,063) | (2,677) | (911) | ||
| Investment income, nonoperating | 129 | (1,891) | 56 | |||||
| Debt instrument, convertible, beneficial conversion feature | 642 | 15 | ||||||
| Other nonoperating income | 101 | 11 | ||||||
| Interest and debt expense | (151) | (3) | 215 | 6 | (126) | 54 | ||
| Loss from continuing operations before equity method investments, income taxes: | (3,439) | (2,894) | (3,620) | (2,155) | (3,608) | (2,017) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | 151 | 3 | (215) | (6) | 126 | (54) | ||
| Loss from continuing operations: | (3,287) | (2,890) | (3,835) | (2,160) | (3,481) | (2,070) | ||
| Loss before gain (loss) on sale of properties: | ✕ | (3,287) | (2,890) | (3,835) | (2,160) | (3,481) | (2,070) | |
| Net loss available to common stockholders, diluted: | (3,287) | (2,890) | (3,835) | (2,160) | (3,481) | (2,070) | ||
Comprehensive Income ($ in thousands)
| 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (3,287) | (2,890) | (3,835) | (2,160) | (3,481) | (2,070) | ||
| Comprehensive loss, net of tax, attributable to parent: | (3,287) | (2,890) | (3,835) | (2,160) | (3,481) | (2,070) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.